ResearcherUniversity of Southern CaliforniaActive in the last 2 years
Afsaneh Barzi
Matched on ORCID iD 0000-0002-0032-2988; OpenAlex author ID A5078937721. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER… Co-author DOI 10.3389/fonc.2024.1339302↗
- Pancreatic Adenocarcinoma: Real World Evidence of Care Delivery in AccessHope Data. Co-author DOI 10.3390/jpm13091377↗
- Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United States. Co-author DOI 10.1097/mpa.0000000000001479↗
- Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results. First author DOI 10.1007/s10147-014-0730-2↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daruka Mahadevan · 1 shared paper, 2024 · strength 0.22
- Kabir Mody · 1 shared paper, 2024 · strength 0.22
- Andrea Wang‐Gillam · 1 shared paper, 2024 · strength 0.22
- Todd M. Sachs · 1 shared paper, 2023 · strength 0.17
- David T. Wong · 1 shared paper, 2023 · strength 0.17
- Douglas Adam Rubinson · 1 shared paper, 2023 · strength 0.17
- Vincent M. Chung · 1 shared paper, 2023 · strength 0.17
- Daniel H. Ahn · 1 shared paper, 2020 · strength 0.11
- Rebecca Anne Miksad · 1 shared paper, 2020 · strength 0.11
- Tanios Bekaii‐Saab · 1 shared paper, 2020 · strength 0.11
- Thomas John Semrad · 1 shared paper, 2015 · strength 0.04
- Edward Jae-Hoon Kim · 1 shared paper, 2015 · strength 0.04
- Heinz‐Josef Lenz · 1 shared paper, 2015 · strength 0.04
- Primo N. Lara · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.